Do you want to read an article? Please log in or register.
Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial - a randomized, double-blinded, placebo-controlled trial
Type 1 DiabetesObesity and Bariatric Surgery